0000927066-23-000231.txt : 20231218 0000927066-23-000231.hdr.sgml : 20231218 20231218184418 ACCESSION NUMBER: 0000927066-23-000231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231214 FILED AS OF DATE: 20231218 DATE AS OF CHANGE: 20231218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rodriguez Javier CENTRAL INDEX KEY: 0001415548 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 231495143 MAIL ADDRESS: STREET 1: 601 HAWAII ST. CITY: EL SEGUNDO STATE: CA ZIP: 90245 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 4 1 wk-form4_1702943047.xml FORM 4 X0508 4 2023-12-14 0 0000927066 DAVITA INC. DVA 0001415548 Rodriguez Javier C/O DAVITA INC. 2000 16TH STREET DENVER CO 80202 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-12-14 4 M 0 500000 67.80 A 833299 D Common Stock 2023-12-14 4 D 0 311581 108.80 D 521718 D Common Stock 2023-12-14 4 F 0 82716 108.80 D 439002 D Stock Appreciation Rights 67.80 2023-12-14 4 M 0 500000 0 D 2022-11-04 2024-11-04 Common Stock 500000 2000000 D Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4. Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4. The Stock Appreciation Rights were granted on November 4, 2019, which vested 50% each on November 4, 2022 and November 4, 2023. /s/ Stephanie N. Berberich, Attorney-in-Fact 2023-12-18